( NYSE:NVO )

News from Novo Nordisk Inc. A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages.

Latest

Oct 27, 2016, 09:00 ET Novo Nordisk to present eight abstracts at the 4th annual ObesityWeek in New Orleans, LA

Novo Nordisk, a global leader in obesity care, today announced that data from eight abstracts, including six posters and two oral presentations,...


Sep 27, 2016, 12:48 ET Working Mother names Novo Nordisk Inc. one of its "100 Best Companies"

 Working Mother magazine today recognized Novo Nordisk Inc. as one of the 2016 "Working Mother 100 Best Companies." Novo Nordisk, a world...


Sep 08, 2016, 14:16 ET Novo Nordisk Inc. issues voluntary nationwide recall of six batches of GlucaGen® HypoKit® (glucagon [rDNA origin] for injection) due to detached needles on the syringe in the kit

 Novo Nordisk Inc. is recalling six batches of the GlucaGen® HypoKit® in the U.S. due to two customer complaints from the UK and...


Nov 04, 2015, 12:30 ET Data presented at ObesityWeek showed Saxenda® (liraglutide [rDNA origin] injection) treatment demonstrated significant and sustained weight loss over three years compared with placebo

 Today, new data from the phase 3a SCALE™ (Satiety and Clinical Adiposity: Liraglutide Evidence in Non-Diabetic and Diabetic adults)...


Sep 29, 2015, 10:00 ET Novo Nordisk Launches New Medical Resource for People Living with Hemophilia and Other Rare Bleeding Disorders

Novo Nordisk today announced the launch of RareBleedingDisorders.com, a website providing a range of medical information specifically for people in...


Dec 24, 2014, 17:41 ET Novo Nordisk receives FDA approval for Saxenda® (liraglutide [rDNA origin] injection) for chronic weight management

Novo Nordisk today announced that the Food and Drug Administration (FDA) has approved the new drug application (NDA) for Saxenda® (liraglutide...


Oct 15, 2014, 10:00 ET Jackie Scanlan joins Novo Nordisk Inc. as Corporate Vice President, Human Resources

 Novo Nordisk Inc., the North American affiliate of the global healthcare company with more than 90 years of innovation and leadership in...


Sep 11, 2014, 20:49 ET Saxenda® for the treatment of obesity receives positive 14-1 vote in favor of approval from FDA Advisory Committee

Novo Nordisk today announced that the Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC) of the Food and Drug Administration (FDA) has...


Jan 30, 2014, 11:34 ET Novo Nordisk Promotes Eddie Williams to Senior Vice President

Novo Nordisk (NYSE: NVO), a global healthcare company with 90 years of innovation and leadership in diabetes care, announced the promotion of...


Jan 22, 2013, 17:00 ET Novo Nordisk Launches New Program To Recognize People With Type 2 Diabetes Who Give Back To Their Communities

 Novo Nordisk, a world leader in diabetes care, today kicked off the first NovoLog® Community Star contest. As part of the program, type...


Jan 04, 2013, 10:47 ET Novo Nordisk Inc. Appoints Curtis G. Oltmans as Corporate Vice President and General Counsel, Legal and Quality Affairs

 Novo Nordisk Inc., a global healthcare company with 90 years of innovation and leadership in diabetes care, announced that Curtis G. Oltmans...


Apr 27, 2012, 06:00 ET Novo Nordisk plans 15 percent expansion of U.S. work force in 2012

 Novo Nordisk Inc. (NYSE: NVO), a global healthcare company with 89 years of innovation and leadership in diabetes care, today announced plans...


Apr 26, 2012, 09:00 ET Novo Nordisk Honored as a Best Place to Work in New Jersey

 Novo Nordisk Inc. (NYSE: NVO), a global healthcare company with 89 years of innovation and leadership in diabetes care, was named as one of...


Sep 07, 2011, 12:02 ET Novo Nordisk Inc. Appoints Eddie Li as Vice President, Regulatory Affairs

Novo Nordisk Inc. announced today that Dr. Eddie Li, has been appointed to join the diabetes leader as Vice President, Regulatory Affairs starting...


Oct 19, 2010, 09:00 ET Novo Nordisk Explores Why Fewer Than 12 Percent of Eligible Medicare Patients Use Free Diabetes Screening Benefit

Novo Nordisk Inc., a leader in diabetes care, explores how fewer than 12 percent of those eligible to use the free Medicare diabetes screening...


Sep 16, 2010, 10:45 ET Novo Nordisk Named a 2010 Working Mother 100 Best Company

Novo Nordisk Inc. has been selected as a Working Mother 100 Best Company for being one of the nation's top companies for family-friendly benefits....


Aug 23, 2010, 09:00 ET Novo Nordisk Inc. Announces Exclusive Agreement With Upsher-Smith Laboratories, Inc. to Market Vagifem® 10 mcg

Novo Nordisk Inc. today announced that it has signed an exclusive agreement with Upsher-Smith Laboratories, Inc. to market Vagifem® (estradiol...


Jul 12, 2010, 12:00 ET Novo Nordisk Addresses Innovation in Diabetes Care in Second Issue of Industry Resource for Information on Diabetes and Chronic Disease

Novo Nordisk Inc., a global healthcare company and leader in diabetes care, today announced the second issue of the Novo Nordisk BlueSheet, a...


May 20, 2010, 08:45 ET Vagifem® 10 mcg to Replace Vagifem® 25 mcg Formulation for Atrophic Vaginitis

Novo Nordisk Inc. announced today that Vagifem® (estradiol vaginal tablets) 10 mcg will become the only available formulation of Vagifem®...


May 11, 2010, 12:00 ET Novo Nordisk Awards More Than $300,000 in Grants to Support Education and Community Health Programs

Novo Nordisk Inc., a world leader in diabetes care, is taking the lead to help improve education and community health in the Princeton area by...


Apr 29, 2010, 15:00 ET Novo Nordisk Named 'Best Place to Work in New Jersey'

Novo Nordisk Inc., a global healthcare company and leader in diabetes care, has been recognized as the "Best Place to Work in New Jersey" by...


Mar 15, 2010, 10:00 ET Novo Nordisk Awards Grants to Support Summer Camp for Children with Diabetes

Novo Nordisk Inc., a world leader in diabetes care, announced that it has awarded funds to support scholarships and capital improvements to...


Oct 30, 2009, 09:00 ET Novo Nordisk is Changing Possibilities in Hemophilia

Novo Nordisk Inc. announced the re-launch of its changing possibilities in hemophilia(TM) campaign through a rebranded Web site and a new...


Jan 22, 2009, 14:18 ET Novo Nordisk Makes its Debut in FORTUNE's '100 Best Companies to Work For'

Novo Nordisk, a global healthcare company focusing on diabetes care, has been named in FORTUNE's 2009 "100 Best Companies to Work For" awards...


Nov 06, 2008, 11:03 ET Columbus Medicare Diabetes Screening Project Cited as Model for State by Lt. Governor Casey Cagle

Columbus Civic and Community Leaders Kick-off Statewide Initiative to Advance Diabetes Screening for Medicare Beneficiaries Lt....